Table 5 Logistic regression of risk factors for recurrence of atrial fibrillation

History congestive cardiac failure

2.84

1.05–7.65

0.04

Peripheral vascular disease

2.06

0.99–4.27

0.05

Cerebrovascular disease

0.40

0.14–1.10

0.07

SIRS

1.77

0.96–3.27

0.07

Ischaemic heart disease

1.71

0.91–3.23

0.10

Mitral valve disease

0.25

0.05–1.26

0.09

Metastatic tumour

3.03

0.79–11.6

0.11

Leukaemia

3.03

0.79-11.61

0.11

Age

1.02

1.00–1.04

0.12

Body mass index

0.96

0.92–1.00

0.06

Concurrent use of beta-blockers

1.50

0.83-2.73

0.18

Concurrent use of digoxin*

5.06

2.20–11.67

<0.001

Ceasing amiodarone while on inotrope infusion

8.76

3.58–21.4

<0.001

Delay of infusion after bolus dose of amiodarone

1.86

1.02–3.44

0.05

Receiving a bolus dose and infusion of amiodarone

0.44

0.23–0.86

0.02

Remaining on amiodarone to discharge from ICU

0.02

0.01–0.05

<0.001

Ceasing amiodarone while on inotrope infusion

5.89

1.86–18.6

0.003

Remaining on amiodarone for duration of ICU admission

0.01

0.003–0.04

<0.001

SIRS

4.21

1.32–13.4

0.02